View in EDS HTML Full Text PDF Full Text

PARP inhibition suppresses the emergence of temozolomide resistance in a model system.

Saved in:
Bibliographic Details
Title: PARP inhibition suppresses the emergence of temozolomide resistance in a model system.
Authors: Yuan AL; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Meode M; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Tan M; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Maxwell L; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Bering EA; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Pedersen H; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Willms J; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Liao J; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Black S; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Cairncross JG; Departments of Clinical Neurosciences, University of Calgary, HRIC 2AA-07, 3280 Hospital Drive NW, Calgary, AB, T2N4, Canada.; Departments of Oncology, University of Calgary, Calgary, AB, Canada.; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Blough MD; Departments of Clinical Neurosciences, University of Calgary, HRIC 2AA-07, 3280 Hospital Drive NW, Calgary, AB, T2N4, Canada. mdblough@ucalgary.ca.; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada. mdblough@ucalgary.ca.
Source: Journal of neuro-oncology [J Neurooncol] 2020 Jul; Vol. 148 (3), pp. 463-472. Date of Electronic Publication: 2020 Jun 19.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32562246
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PARP inhibition suppresses the emergence of temozolomide resistance in a model system.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yuan+AL%22">Yuan AL</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Meode+M%22">Meode M</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Tan+M%22">Tan M</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Maxwell+L%22">Maxwell L</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Bering+EA%22">Bering EA</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Pedersen+H%22">Pedersen H</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Willms+J%22">Willms J</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Liao+J%22">Liao J</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Black+S%22">Black S</searchLink>; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Cairncross+JG%22">Cairncross JG</searchLink>; Departments of Clinical Neurosciences, University of Calgary, HRIC 2AA-07, 3280 Hospital Drive NW, Calgary, AB, T2N4, Canada.; Departments of Oncology, University of Calgary, Calgary, AB, Canada.; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada.; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Blough+MD%22">Blough MD</searchLink>; Departments of Clinical Neurosciences, University of Calgary, HRIC 2AA-07, 3280 Hospital Drive NW, Calgary, AB, T2N4, Canada. mdblough@ucalgary.ca.; Clark H. Smith Brain Tumour Centre, University of Calgary, Calgary, AB, Canada. mdblough@ucalgary.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309335%22">Journal of neuro-oncology</searchLink> [J Neurooncol] 2020 Jul; Vol. 148 (3), pp. 463-472. <i>Date of Electronic Publication: </i>2020 Jun 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309335 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7373 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220167594X%22">0167594X </searchLink><i>NLM ISO Abbreviation: </i>J Neurooncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32562246
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11060-020-03561-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 463
    Titles:
      – TitleFull: PARP inhibition suppresses the emergence of temozolomide resistance in a model system.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yuan AL
      – PersonEntity:
          Name:
            NameFull: Meode M
      – PersonEntity:
          Name:
            NameFull: Tan M
      – PersonEntity:
          Name:
            NameFull: Maxwell L
      – PersonEntity:
          Name:
            NameFull: Bering EA
      – PersonEntity:
          Name:
            NameFull: Pedersen H
      – PersonEntity:
          Name:
            NameFull: Willms J
      – PersonEntity:
          Name:
            NameFull: Liao J
      – PersonEntity:
          Name:
            NameFull: Black S
      – PersonEntity:
          Name:
            NameFull: Cairncross JG
      – PersonEntity:
          Name:
            NameFull: Blough MD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2020 Jul
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7373
          Numbering:
            – Type: volume
              Value: 148
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of neuro-oncology
              Type: main
ResultId 1